Article
A novel EPM2A mutation yields a slow progression form of Lafora disease.
Epilepsy research - 1 Sept 2018
Garcia-Gimeno Maria Adelaida, Rodilla-Ramirez Pilar Natalia, Viana Rosa, Salas-Puig Xavier, Brewer M Kathryn, Gentry Matthew S, Sanz Pascual
Abstract excerpt
Lafora disease (LD, OMIM 254780) is a rare disorder characterized by epilepsy and neurodegeneration leading patients to a vegetative state and death, usually within the first decade from the onset of the first symptoms. In the vast majority of cases LD is related to mutations in either the EPM2A gene (encoding the glucan phosphatase laforin) or the EPM2B gene (encoding the E3-ubiquitin ligase malin). In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
